Innate-like T Cell Biology in the Tumor Microenvironment Implications for Cancer Immunotherapy

Area of Science:

• Immunology
• Cancer Biology
• Cellular Immunology

Background:

• Innate-like T cells (ILTCs) bridge innate and adaptive immunity.
• Key ILTC subsets include invariant natural killer T (iNKT) cells, mucosa-associated invariant T (MAIT) cells, and γδ T cells.
• ILTCs recognize non-classical antigens presented via CD1d, MR1, and butyrophilin-dependent pathways, detecting stressed or transformed cells.

Purpose of the Study:

• To review the multifaceted roles of ILTCs in tumor surveillance and immune escape.
• To discuss the mechanisms of ILTC suppression within the tumor microenvironment.
• To explore therapeutic strategies aimed at restoring ILTC function in cancer.

Main Methods:

• This review synthesizes existing literature on ILTCs in cancer immunology.
• Analysis of non-classical antigen presentation pathways utilized by ILTCs.
• Examination of factors contributing to ILTC suppression in established tumors.

Main Results:

• ILTCs contribute to early tumor control by activating other immune cells like dendritic cells and NK cells.
• Tumor microenvironments suppress ILTCs through mechanisms including inhibitory cytokines, hypoxia, and metabolic constraints (e.g., lactate, kynurenine).
• Transcriptional regulators like TOX, NR4A, and BATF are implicated in ILTC hyporesponsiveness.

Conclusions:

• ILTCs play a dual role in cancer, promoting surveillance but also being susceptible to suppression.
• Understanding ILTC suppression mechanisms is vital for developing effective cancer immunotherapies.
• Targeting ILTCs represents a potential strategy to enhance anti-tumor immunity.